BANAMINE GRANULES DIN 00465291
Status: Cancelled Post Market
Holder: SCHERING-PLOUGH CANADA INC
Molecule: FLUNIXIN (FLUNIXIN MEGLUMINE)
Health Canada record
| Active ingredient(s) | FLUNIXIN (FLUNIXIN MEGLUMINE) 25 MG |
|---|---|
| Dosage form | Granules |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1980 |
| Current status date | 04-Aug-2009 |
| Source | Health Canada DPD |
Establishment licence of the holder
Schering-Plough Mexico S.A. DE C.V. — licence , not currently licensed, last inspection rating C (2022-08-29).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLUNIXIN (FLUNIXIN MEGLUMINE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00465305 | BANAMINE | INTERVET CANADA CORP | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 02457180 | BANAMINE | INTERVET CANADA CORP | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 02240510 | FLUNAZINE | BIMEDA-MTC ANIMAL HEALTH INC | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 02563584 | FLUTREXIN | MODERN VETERINARY THERAPEUTICS LLC | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 02550474 | SOLNIXON | BIMEDA-MTC ANIMAL HEALTH INC | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 02234061 | SOLVEZINE | NORBROOK LABORATORIES LTD. | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 02231381 | CITATION INJECTION | BAYER INC., ANIMAL HEALTH | Liquid | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Cancelled Post Market |
| 02230652 | CRONYXIN INJECTION | CROSS VETPHARM GROUP LTD | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Cancelled Post Market |
| 02239149 | INFLUX-50 (FLUNIXIN MEGLUMINE INJECTION) STERILE INJECTABLE SOLUTION | VETOQUINOL N A INC | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Cancelled Post Market |
| 02248807 | SUPPRESSOR | NORBROOK LABORATORIES LTD. | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Cancelled Post Market |
| 02478951 | VETONIXIN | NORBROOK LABORATORIES LTD. | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 9238 | 2007-12-12 | Supplement to a New Drug Submission (SNDS) | ALTERNATE SOURCE OF ACTIVE INGREDIENT |